VELCADE (bortezomib) for Injection is indicated for the treatment of patients with multiple myeloma.
VELCADE (bortezomib) for Injection is indicated for the treatment of patients with mantle cell lymphoma.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education